Is Your Equity Story Supported by the Evidence?

17 Nov 2026

The Investor Relation Society

IR Society News

The Society spoke to Stijn Broekema, Co-Founder & CEO of ValueLens, to explore how IR teams can distinguish market noise from genuine warning signs, anticipate activist arguments and help management identify opportunities to create value. 

Stijn, how should IROs act as internal challengers where the company’s strategy or investment case is not resonating with the market?

One of the most valuable things IR can do is bring an independent, outside-in perspective into the organisation. 

Management sees the business through its plans and performance measures. Investors see it through expectations for growth, profitability, capital efficiency and risk. Those perspectives do not always align. 

An effective IRO should identify those disconnects and challenge management constructively. A company may meet its internal targets while trading at a discount to peers. The question isn’t simply how to communicate better, but whether investors see something management is overlooking. 

The best IR teams don’t simply advocate for management’s equity story. They help test whether it is supported by the evidence. 

 

How can an IRO distinguish between short-term market noise and feedback that points to a more fundamental strategic issue? 

The key is to move from observing share price movements to understanding what drives valuation. 

Not every market movement indicates a strategic problem. Persistent valuation differences relative to relevant peers, however, may reflect real differences in growth, profitability, capital intensity or risk. 

One useful approach is to reverse-engineer the expectations embedded in the share price. What growth, margins and returns would justify today’s valuation, and how do they compare with management’s ambitions? 

This changes the conversation from “Why is our share price down?” to “What does the market believe about our future, and where does that differ from our own assessment?” 

 

Are companies making enough use of peer, sector and valuation data to understand where they may be vulnerable to activist arguments? 

There’s considerable room for improvement. 

Most listed companies monitor valuation multiples and relative performance. But knowing that a company trades at a discount is different from understanding why and whether it represents a value-creation opportunity. 

At ValueLens, we’ve built our methodology with Tim Koller, lead author of Valuation: Measuring and Managing the Value of Companies, around a fundamental principle: understanding valuation requires understanding the underlying drivers of value, not just comparing multiples. 

That means examining growth, margins, returns on invested capital and the expectations reflected in the share price. 

Activists often build arguments around gaps between current performance and potential, questioning portfolio composition, efficiency, capital allocation or execution. Yet a discount does not automatically imply an opportunity. A discounted company may be fairly valued, while one without an obvious discount may still have significant potential. 

Companies should ask these questions long before an activist arrives. 

 

How can IR teams bring together quantitative data, such as share register movements, trading activity and valuation analysis, with qualitative investor feedback? 

The value comes from combining these sources into one interpretation rather than treating them as separate reporting exercises. 

Quantitative analysis reveals what is happening; qualitative engagement helps explain whether investors are concerned about capital allocation, margins, execution or management credibility. 

The challenge is often not a lack of data, but translating it into something management can use. 

I saw this with a US mega-cap company. Despite sophisticated teams and extensive data, our outside-in assessment provided a perspective it hadn’t seen before: nobody had brought everything together into this kind of strategic insight. 

Having the best data is not the same as knowing what it means. IR can connect market observations to the drivers of value and frame questions the CFO, CEO and board can act upon. 

 

What are the most common warning signs that a company may be vulnerable to an activist campaign? 

Vulnerability usually emerges from a combination of factors that create a credible argument for change. At ValueLens, we seek to mirror how a sophisticated activist might assess a target, in three stages. 

First, screening: is there a reason to look closer? Sustained share price underperformance, a persistent discount to peers, deteriorating analyst sentiment, negative news flow or changes in the shareholder base may warrant examination. 

Second, diagnostics: is there a case for change? An activist thesis usually takes one of three forms: 

A fix-it thesis: performance is below potential in growth, margins or returns on invested capital. 

An unlock thesis: value is trapped through underperforming segments, poor acquisitions, an inefficient balance sheet or excessive leverage. 

Or, a governance and incentives thesis: leadership incentives are not sufficiently aligned with value creation. 

The objective is to identify what is fixable, what is structural and what the market may have wrong. 

Third, upside assessment: is there a compelling opportunity? The question is how much value the strongest thesis could realistically unlock and how achievable the change would be. 

Companies should understand the strongest activist case against them before somebody else builds it. Applied proactively, this can improve performance, strengthen the equity story and create long-term value. 

 

If an IR team wanted to improve its use of data and insight now, where should it begin? 

I’d start with three practical questions. First, how does the market value our company relative to genuinely comparable businesses? Go beyond headline multiples and examine differences in growth, profitability, capital efficiency and risk. 

Second, what would we have to believe to justify today’s share price? What growth and returns on capital does the valuation assume, and does that match our plan? 

Third, where are the biggest disconnects between the market’s perspective and our own? These could concern performance, growth opportunities, capital allocation or the credibility of strategic targets. 

The next step is to discuss those findings with finance and strategy colleagues rather than keeping them within IR. 

A focused, repeatable outside-in assessment can generate valuable insights without a large analytical team or complex infrastructure. 

This is the thinking behind what we do: helping IR and leadership teams see their company as investors and activists do, understand what the share price assumes about growth and returns, and identify opportunities to create value. 

The ambition is for IR not only to understand investors, but to help management understand what would justify today’s valuation and what the company can do about it. 

 

Stijn Broekema is Co-Founder and CEO of ValueLens. His career includes eight years at McKinsey's Strategy & Corporate Finance practice. He also runs sessions for executives, boards and IR professionals on how investors look at a company, and how to use that view to create long-term shareholder value.